In addition, we showed that, among BRAF‐wild‐type cases, both KRAS c.34G>T (p.G12C) mutation and KRAS mutations other than c.34G>T were associated with higher colorectal cancer‐specific mortality compared with KRAS‐wild‐type cases. This evidence concerns the gene KRAS and colorectal cancer.